Zohreh Sajjadi-Hashemi

Title: Zohreh Sajjadi-Hashemi: Innovator in Tricyclic Compounds and PBK Inhibitors

Introduction

Zohreh Sajjadi-Hashemi is a prominent inventor based in Schenectady, NY, known for her significant contributions to the field of medicinal chemistry. She holds two patents that focus on tricyclic compounds and PBK inhibitors, which are crucial for the treatment of PBK-related diseases, including cancer. Her work is instrumental in advancing therapeutic options for patients suffering from these conditions.

Latest Patents

Zohreh's latest patents include innovative tricyclic compounds that serve as PBK inhibitors. These compounds are designed to target and inhibit PBK, making them valuable in the treatment of various diseases, particularly cancer. The development of these compounds showcases her expertise and commitment to improving healthcare outcomes.

Career Highlights

Zohreh Sajjadi-Hashemi is currently associated with Oncotherapy Science, Incorporated, where she applies her knowledge and skills to further research and development in oncology. Her work at this company emphasizes her dedication to finding effective treatments for cancer patients.

Collaborations

Zohreh collaborates with notable colleagues, including Yusuke Nakamura and Yo Matsuo, who contribute to her research efforts. These collaborations enhance the scope and impact of her work in the field of medicinal chemistry.

Conclusion

Zohreh Sajjadi-Hashemi is a trailblazer in the development of tricyclic compounds and PBK inhibitors, making significant strides in cancer treatment. Her innovative work and collaborations position her as a key figure in the ongoing fight against cancer.